NeuroPace (NPCE) Cost of Revenue (2020 - 2026)

NeuroPace's Cost of Revenue history runs 7 years deep, the most recent figure standing at $4.0 million for Q1 2026.

• In Q1 2026, Cost of Revenue fell 63.46% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $32.9 million (up 156.0% YoY), while the FY2025 annual figure was $46.6 million, up 123.72% from the prior year.
• Cost of Revenue was $4.0 million for Q1 2026 at NeuroPace, down from $10.9 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $12.6 million in Q3 2025 to a low of -$8.9 million in Q4 2024.
• Historically, Cost of Revenue has averaged $4.8 million across 5 years, with a median of $4.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Cost of Revenue sank 299.17% in 2024, then soared 222.92% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $4.0 million in 2022, then climbed by 12.07% to $4.5 million in 2023, then tumbled by 299.17% to -$8.9 million in 2024, then jumped by 222.92% to $10.9 million in 2025, then plunged by 63.24% to $4.0 million in 2026.
• The last three Cost of Revenue figures came in at $4.0 million (Q1 2026), $10.9 million (Q4 2025), and $12.6 million (Q3 2025), per Business Quant data.